계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
SanReno Therapeutics
company
About
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies.
Highlights
Details
- Last Funding Type
- Funding Round
- Last Funding Money Raised
- $40M
- Industries
- Biotechnology,Therapeutics
- Founded date
- Jan 1, 2020
- Operating Status
- Active
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies in the People’s Republic of China, Hong Kong, Macau, Taiwan and Singapore (the “Territory”). SanReno Therapeutics formed with JV of Chinook Therapeutics and Frazier Healthcare Partners and Pivotal bioVenture Partners China.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$40M
SanReno Therapeutics has raised a total of
$40M
in funding over 2 rounds. Their latest funding was raised on
Nov 30, 2021 from a Funding Round round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 30, 2021 | Funding Round | $40M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
SanReno Therapeutics is funded by 1 investors.
Versant Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Versant Ventures
|
— | Funding Round |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
